1. Home
  2. ASTC vs XCUR Comparison

ASTC vs XCUR Comparison

Compare ASTC & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

N/A

Current Price

$4.82

Market Cap

10.5M

Sector

Industrials

ML Signal

N/A

Logo Exicure Inc.

XCUR

Exicure Inc.

N/A

Current Price

$1.01

Market Cap

9.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTC
XCUR
Founded
1984
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
9.2M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
ASTC
XCUR
Price
$4.82
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.8K
★ 39.0K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2600.00
83.37
EPS
★ 0.25
N/A
Revenue
★ $1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$44.02
P/E Ratio
$21.40
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.92
$0.88
52 Week High
$68.85
$9.48

Technical Indicators

Market Signals
Indicator
ASTC
XCUR
Relative Strength Index (RSI) 32.20 42.41
Support Level $4.63 $0.99
Resistance Level $7.76 $1.52
Average True Range (ATR) 0.41 0.13
MACD 0.02 -0.00
Stochastic Oscillator 19.55 29.38

Price Performance

Historical Comparison
ASTC
XCUR

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology company. It creates, operates and scales businesses through its subsidiaries and technology platforms, including space-related technology, instrumentation, mass spectrometry, gas chromatography, process-control and environmental analysis technologies. It is evaluating opportunities to identify, develop and commercialize technologies with potential applications in space, defense, industrial, environmental, quantum computing, AI, semiconductor materials, lunar infrastructure and related markets. Its products include Tracer 1000 ETD, tracer 1000 NTD, Labrador HHGC, Fenceline GC, AgLab 1000-D2, among others. It operates in single segment.

About XCUR Exicure Inc.

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.

Share on Social Networks: